Metabolic bone disease and parenteral nutrition
โ Scribed by Cynthia Hamilton; Douglas L. Seidner
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 685 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1522-8037
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in patients with primary biliary cirrhosis-associated ost
In the 1950s, Mertz and Schwarz published a series of experiments providing evidence that chromium (Cr) is an essential nutrient forming the active component of the "glucose tolerance factor." This factor enhances the binding of insulin to its receptors, potentiating the action of insulin on carbohy